Form D · Other
Animal Biosciences, Inc.
Boston, MA · CIK 0001826176
Offering snapshot reported Sep 9, 2026 · SEC filing
- Reported sold
- $2.32M Offering amount: $2.61M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2026 | Initial | $2,320,000 | No comparison | 15 | SEC filing |
| Jan 7, 2022 | Initial | $1,699,997 | No comparison | 3 | SEC filing |
| Sep 25, 2020 | Initial | $633,531 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596826
Source: Form D, filed Sep 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jared Barlow | Director |
| Brian Malone | Director |
| Virginia Rentko | Director, Executive |
| Nick Sinclair | Director, Executive |
| Nicholas Sinclair | Director |
| Petr Sramek | Director |
Issuer details
Industry: Other (See others in industry)
Address:
361 Newbury St Fl 5
Boston, MA, 02115
Boston, MA, 02115